Financial News
All News about Springworks Therapeutics Inc
![](https://ml.globenewswire.com/media/cb189515-a53a-4aaa-bbc2-e66b4b60a4bc/small/springworks-400x400px-jpg.jpg)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
4 Analysts Have This to Say About SpringWorks Therapeutics
December 01, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6947.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/07/aapharma_9.png?width=1200&height=800&fit=crop)
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
September 07, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/23/screenshot_2022-11-23_at_7.14.20_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_689.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/06/aapharma_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2117.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
![](https://ml.globenewswire.com/media/53bd4a0d-29c3-4a6a-8721-4eb69f5c3f0f/small/r-logo-color-darkfont-png.png)
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image-nio.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image41.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14477.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/11/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/10/image_4_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7976.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/20/42c653e5-73c4-4bc5-a724-89e510dc932f.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20220616005701/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/13/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/27/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.